New indication in Europe for Roche colon cancer drug

Tuesday 30 March 2010

The Roche group said that its cancer drug, Xeloda (capecitabine) has been approved in Europe in combination with the chemotherapy drug, oxaliplatin, for the adjuvant treatment of patients with early colon cancer. The combination is called Xelox.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland